Liposomal Doxorubicin in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of liposomal doxorubicin in treating
patients with prostate cancer that has not responded to hormone therapy.